Financial Gravity Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Financial Gravity Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11	Closed	-$445	–	1634
2024 Q1	$445	Buy	+11	New	+$385	﹤0.01%	1391
2023 Q3	–	Sell	-21	Closed	-$237	–	1344
2023 Q2	$237	Buy	+21	New	+$477	﹤0.01%	1147
2023 Q1	–	Sell	-23	Closed	-$908	–	1237
2022 Q4	$908	Sell	23 -217	-90%	-$4.38K	﹤0.01%	686
2022 Q3	$2.07K	Buy	+240	New	+$4.23K	0.07%	287

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Financial Gravity Asset Management's COLL Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 11 shares — an estimated $445 sold.

Financial Gravity Asset Management first reported a position in COLL in Q3 2022 and held it in 4 quarters. The position peaked at $2.07K in Q3 2022. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

Financial Gravity Asset Management reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Financial Gravity Asset Management sold 11 Collegium Pharmaceutical shares in Q2 2024, an estimated $445.
Financial Gravity Asset Management first reported a position in Collegium Pharmaceutical in Q3 2022 and held it in 4 quarters.
Financial Gravity Asset Management's Collegium Pharmaceutical position peaked at $2.07K in Q3 2022.
229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.